Target intelligence / Profile preview

Rh-associated glycoprotein (RHAG)

Target
RHAG
Molecular classification
Transporter, Solute carrier family (specifically SLC42A1), Blood group antigen complex component, Membrane protein
01

Overview

Rh-associated glycoprotein (RHAG) is an ammonia transporter protein encoded by the RHAG gene and primarily expressed in human erythrocytes[1][3]. It is a component of the multisubunit Rh antigen complex, which includes RHAG, Rh30 (D/CE) polypeptides, CD47, LW, and glycophorin B[1][4]. RHAG facilitates the movement of ammonia (NH₃) and methylamine across the red blood cell membrane and may also act as a gas channel for CO₂ and possibly O₂ and nitric oxide[2][3]. It is structurally homologous to ammonium transporter families found in bacteria and yeast. RHAG is essential for proper presentation of the Rh blood group antigens on the cell surface; mutations can result in hereditary stomatocytosis and other blood cell membrane disorders[1][4]. It is referenced as CD241 in immunophenotyping applications and is a member of the solute carrier family under the gene name SLC42A1[1]. No approved drugs are known to directly target RHAG, but its dysfunction has clinical implications in hematology and transfusion medicine.

Other names
Ammonium transporter Rh type ARHAGRH50CD241Rh50ARh family type A glycoproteinRh type A glycoproteinSLC42A1Erythrocyte membrane glycoprotein Rh50Erythrocyte plasma membrane 50 kDa glycoproteinRhesus blood group family type A glycoproteinRhesus blood group-associated ammonia channelRhesus blood group-associated glycoproteinOHSTRH2RHNRRh50GP50-KDRhesus associated polypeptide
02

Biological functions

Ammonia transport across red blood cell membranesFacilitates passage of neutral gases (CO₂, NH₃)Component required for surface expression of Rh blood group antigens
03

Disease associations

Hemolytic anemia (specifically hereditary stomatocytosis and Rh deficiency syndrome)Blood transfusion compatibility (Rh antigen status)Other red cell membrane disorders
04

Safety considerations

Mutations can lead to hemolytic conditions (hereditary stomatocytosis, Rh deficiency syndrome)Blood transfusion incompatibility risks due to antigenicity
05

Biomarkers

Mutations in RHAG as diagnostic for hereditary stomatocytosis and Rh deficiency syndromeRhAG expression can serve as a red cell marker (CD241)

Beyond the preview

Go deeper on Rh-associated glycoprotein (RHAG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rh-associated glycoprotein (RHAG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call